Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
McKesson
Teva
Cipla
UBS
Queensland Health
US Department of Justice
Daiichi Sankyo
Moodys
Chubb

Generated: February 23, 2018

DrugPatentWatch Database Preview

DEXTROSE 25% Drug Profile

« Back to Dashboard

Which patents cover Dextrose 25%, and when can generic versions of Dextrose 25% launch?

Dextrose 25% is a drug marketed by Hospira and is included in one NDA.

The generic ingredient in DEXTROSE 25% is dextrose. There are eight drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the dextrose profile page.

US Patents and Regulatory Information for DEXTROSE 25%

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira DEXTROSE 25% dextrose INJECTABLE;INJECTION 019445-002 Nov 23, 1998 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
US Department of Justice
Chubb
Healthtrust
Cipla
McKinsey
Merck
Cantor Fitzgerald
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot